GE HealthCare Technologies Inc. filed a current report on August 18, 2026, disclosing that its Board of Directors appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.
Key Highlights
- New CFO appointment: William K. Grogan, age 48, was appointed Chief Financial Officer by the Board of Directors on August 13, 2026, with an effective date of September 14, 2026.
- Interim CFO transition: George A. Newcomb will cease serving as interim Chief Financial Officer on September 14, 2026, and will continue as Controller and Chief Accounting Officer.
- Base salary and bonus: Grogan's offer letter provides for an annual base salary of $900,000 and a target annual bonus opportunity equal to 100% of base salary.
- Long-term incentive: Grogan will receive an annual LTI award with a target grant date value of $3,300,000, plus a one-time sign-on equity award with a grant date value of $4,000,000 in RSUs.
- Cash sign-on payment: Grogan will receive a cash sign-on payment of $550,000, subject to repayment if he resigns on or before the two-year anniversary of its payment or is found to have engaged in conduct warranting termination for cause.
- Prior employer background: Grogan most recently served as Executive Vice President and Chief Financial Officer of Xylem Inc. since October 2023, and previously as Senior Vice President and CFO of IDEX Corporation from January 2017 until September 2023.
GE HealthCare CFO Appointment: Compensation and Transition Details
According to the filing, GE HealthCare Technologies Inc. (NASDAQ:GEHC) disclosed that its Board of Directors appointed William K. Grogan as Chief Financial Officer on August 13, 2026, with his role beginning September 14, 2026. The Talent, Culture, and Compensation Committee of the Board approved Grogan's compensation package on the same date, taking into account his experience and skills, advice from its independent compensation consultant, compensation he will forfeit at his current employer, and GE HealthCare's Total Rewards Philosophy.
The filing states that Grogan's offer letter includes an annual base salary of $900,000, a target annual bonus opportunity of 100% of base salary, and an annual LTI award with a target grant date value of $3,300,000. In consideration of the 2026 annual bonus he will forfeit from his prior employer, Grogan will receive a cash sign-on payment of $550,000. In consideration of pre-2026 LTI forfeited from his prior employer, he will receive a one-time sign-on equity award on September 14, 2026 with a grant date value of $4,000,000, consisting of RSUs vesting 50% on the first anniversary of the grant date and 50% on the second anniversary.
The filing further discloses that Grogan will also receive a 2026 annual LTI award on September 14, 2026, with a grant date value of $3,300,000, consisting of 50% performance stock units tied to GE HealthCare's performance from January 1, 2026 through December 31, 2028 and scheduled to vest in the first quarter of 2029, along with 25% RSUs and 25% stock options each vesting 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. The filing notes there is no arrangement or understanding between Grogan and any other person pursuant to which he was selected, and no reportable transactions exist between Grogan and GE HealthCare under Item 404(a) of Regulation S-K.
What Was Disclosed
GE HealthCare Technologies Inc. reported the appointment of William K. Grogan as CFO effective September 14, 2026, along with the full terms of his compensation package, the transition of the interim CFO role, and Grogan's professional background.




Please wait processing your request...